Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 1 March 2007, Vol. 109, No. 5, pp. 1923-1930.
Prepublished online as a Blood First Edition Paper on October 12, 2006; DOI 10.1182/blood-2006-06-030841.


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
blood-2006-06-030841v1
109/5/1923    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ito, S.
Right arrow Articles by Broxmeyer, H. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ito, S.
Right arrow Articles by Broxmeyer, H. E.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Next Article next article arrow

Submitted June 22, 2006
Accepted October 5, 2006

Mad2 is required for optimal hematopoiesis: Mad2 associates with c-Kit in MO7e cells

Shigeki Ito, Charlie R Mantel, Myung-Kwan Han, Sunanda Basu, Seiji Fukuda, Scott Cooper, and Hal E. Broxmeyer*

Department of Microbiology & Immunology, Indiana University School of Medicine, Indianapolis, IN
Department of Microbiology & Immunology, Indiana University, School of Medicine, Indianapolis, IN

* Corresponding author; email: hbroxmey{at}iupui.edu.

Mitotic arrest deficiency 2 (Mad2) is a component of mitotic spindle checkpoint proteins and essential for accurate chromosome segregation. We investigated a role for Mad2 in hematopoiesis using Mad2 haploinsufficient (Mad2+/-) mice. Mad2+/- bone marrow (BM) and spleen manifested decreased absolute numbers and cycling status of immature, but not mature, hematopoietic progenitor cells. Mad2+/- BM CFU-GM did not manifest synergistic proliferation in response to SCF plus GM-CSF. The percent of annexin V+ cells was higher in Mad2+/- than Mad2+/+ c-Kit+lin- BM after culture with SCF and GM-CSF. However, no significant difference in phosphorylation of extracellular signal-related kinase (Erk1/2) at Thr202/Tyr204 and Akt at Ser473 between Mad2+/- and Mad2+/+ BM c-Kit+lin- cells was observed. Immunoprecipitation assays performed in human MO7e cells demonstrated physical association of c-Kit with Mad2. Moreover, stimulation with SCF plus GM-CSF led to dissociation of Mad2 from c-Kit. Confocal microscopy demonstrated that Mad2 colocalized with c-Kit in the cytoplasm of MO7e cells. These results suggest that Mad2 is involved in synergistic growth of immature hematopoietic progenitor cells in response to SCF plus GM-CSF, effects that may be mediated via physical association of Mad2 with c-Kit.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2006 by American Society of Hematology         Online ISSN: 1528-0020